Sand Hill Global Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-46,609
Closed -$3.8M 109
2017
Q1
$3.8M Buy
46,609
+163
+0.4% +$12.8K 0.49% 44
2016
Q4
$3.34M Buy
46,446
+2,049
+5% +$148K 0.46% 43
2016
Q3
$3.45M Sell
44,397
-1,231
-3% -$99.5K 0.53% 40
2016
Q2
$3.56M Buy
45,628
+1,247
+3% +$99.4K 0.56% 42
2016
Q1
$3.64M Buy
44,381
+1,545
+4% +$126K 0.55% 43
2015
Q4
$3.82M Buy
42,836
+281
+0.7% +$23.9K 0.61% 36
2015
Q3
$3.27M Buy
42,555
+1,775
+4% +$148K 0.52% 42
2015
Q2
$3.41M Buy
40,780
+1,024
+3% +$90.4K 0.55% 47
2015
Q1
$3.59M Buy
39,756
+2,117
+6% +$182K 0.58% 45
2014
Q4
$3.04M Sell
37,639
-3,353
-8% -$265K 0.52% 49
2014
Q3
$3.07M Buy
40,992
+3,573
+10% +$260K 0.51% 47
2014
Q2
$2.56M Buy
37,419
+855
+2% +$58.2K 0.48% 50
2014
Q1
$2.56M Sell
36,564
-22,365
-38% -$1.56M 0.52% 48
2013
Q4
$3.94M Sell
58,929
-20,708
-26% -$1.27M 0.84% 25
2013
Q3
$4.15M Buy
79,637
+19,894
+33% +$1.01M 0.72% 32
2013
Q2
$2.82M Buy
+59,743
New +$2.73M 0.78% 36

Other funds holding CAH

Sand Hill Global Advisors's CAH Position: Q2 2017 in Review

Sand Hill Global Advisors sold out of Cardinal Health (CAH) in Q2 2017, closing a stake of 46,609 shares — an estimated $3.8M sold.

Sand Hill Global Advisors first reported a position in CAH in Q2 2013 and held it in 16 quarters. The position peaked at $4.15M in Q3 2013. 747 funds tracked by Wall St. Rank hold CAH as of Q2 2017.

  • Sand Hill Global Advisors reported no remaining Cardinal Health position as of Q2 2017 after selling out during the quarter.
  • Sand Hill Global Advisors sold 46,609 Cardinal Health shares in Q2 2017, an estimated $3.8M.
  • Sand Hill Global Advisors first reported a position in Cardinal Health in Q2 2013 and held it in 16 quarters.
  • Sand Hill Global Advisors's Cardinal Health position peaked at $4.15M in Q3 2013.
  • 747 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2017.

Based on Sand Hill Global Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.